Biological and neurological activities of astaxanthin (Review)

Mol Med Rep. 2022 Oct;26(4):300. doi: 10.3892/mmr.2022.12816. Epub 2022 Aug 10.

Abstract

Astaxanthin is a lipid‑soluble carotenoid produced by various microorganisms and marine animals, including bacteria, yeast, fungi, microalgae, shrimps and lobsters. Astaxanthin has antioxidant, anti‑inflammatory and anti‑apoptotic properties. These characteristics suggest that astaxanthin has health benefits and protects against various diseases. Owing to its ability to cross the blood‑brain barrier, astaxanthin has received attention for its protective effects against neurological disorders, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, cerebral ischemia/reperfusion, subarachnoid hemorrhage, traumatic brain injury, spinal cord injury, cognitive impairment and neuropathic pain. Previous studies on the neurological effects of astaxanthin are mostly based on animal models and cellular experiments. Thus, the biological effects of astaxanthin on humans and its underlying mechanisms are still not fully understood. The present review summarizes the neuroprotective effects of astaxanthin, explores its mechanisms of action and draws attention to its potential clinical implications as a therapeutic agent.

Keywords: Alzheimer's disease; Parkinson disease; amyotrophic lateral sclerosis; astaxanthin; cerebral ischemia/reperfusion; subarachnoid hemorrhage.

Publication types

  • Review

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Blood-Brain Barrier
  • Humans
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Xanthophylls* / pharmacology
  • Xanthophylls* / therapeutic use

Substances

  • Antioxidants
  • Neuroprotective Agents
  • Xanthophylls
  • astaxanthine

Grants and funding

Funding: No funding was received.